What is Perspectum?
Perspectum is a prominent player in the medical technology sector, operating internationally with a focus on delivering cutting-edge digital solutions. The company's technologies are designed to empower clinicians in providing enhanced care for patients suffering from chronic metabolic diseases, multi-organ pathologies, and various forms of cancer. By leveraging advanced digital tools, Perspectum aims to improve diagnostic accuracy and treatment efficacy, thereby contributing to better patient outcomes and a more efficient healthcare system.
How much funding has Perspectum raised?
Perspectum has raised a total of $90.9M across 2 funding rounds:
Series B
$35.9M
Series C
$55M
Series B (2020): $35.9M with participation from Oxford University, Oxford Sciences Enterprises, Puhua Capital, and HealthQuest Capital
Series C (2023): $55M led by Oppenheimer Holdings
Key Investors in Perspectum
Oppenheimer Holdings
Oppenheimer Holdings is a diversified financial services firm, likely providing strategic financial backing and advisory services to companies within its investment portfolio.
Oxford University
The University of Oxford, a world-renowned research institution, likely invests in companies that align with its cutting-edge scientific and medical research, potentially offering academic and technological collaboration.
Oxford Science Enterprises
Oxford Science Enterprises, an investment company partnered with the University of Oxford, focuses on founding, funding, and building transformational businesses, indicating a strong interest in deep-tech and scientific innovation.
What's next for Perspectum?
The substantial enterprise-level funding secured by Perspectum signals a strong growth trajectory and an expansion of its market reach. This strategic investment is expected to fuel further research and development, enhance product innovation, and broaden the company's global footprint. Perspectum is poised to solidify its position as a leader in digital health solutions, particularly in the complex fields of chronic disease and oncology, by continuing to develop and deploy its advanced technological platforms.
See full Perspectum company page
